Patent Assignment
Reel/Frame 050212/0450
Assignment of Assignor's Interest
Recorded: 2019-08-29
Pages: 5
Assignee
DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MASSACHUSETTS, 02140
Covered Property
(1)
Ligand-Modified Double-Stranded Nucleic Acids
Application:
16/555,193 →
Publication:
US 2020/0031862
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.